Dio Tree
Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.
About
Dio Tree Life Sciences is a biotechnology startup focused on developing a first-in-class small molecule therapy for ovarian cancer. Their innovative approach targets the enzyme DIO3, identified as a significant driver in various cancers, particularly ovarian cancer. Teams look it up for Life Sciences, Oncology, Biotech.
Frequently asked
What does Dio Tree do?
Dio Tree is a Life Sciences company that offers Drug discovery. Teams look it up for Oncology, Biotech, Drug Discovery. It is based in Cambridge, United States and was founded in 2022. Public records show $15M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Dio Tree raised?
Dio Tree has raised a total of $15M in funding. The most recent round on record is Seed.
Where is Dio Tree headquartered?
Dio Tree is headquartered in Cambridge, United States.
When was Dio Tree founded?
Dio Tree was founded in 2022.
What industry does Dio Tree operate in?
Dio Tree operates in Life Sciences, Oncology, Biotech, Drug Discovery, Small Molecule Inhibitor.
What is Dio Tree's current status?
Dio Tree's current operating status is: Inactive.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.